ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0388

Left Ventricular Geometry Abnormalities Are Related to Higher Clinical Activity in Rheumatoid Arthritis Patients

Victor Beltran1, Iris Colunga2, Dionicio A. Galarza-Delgado2, José Ramón Azpiri-López2, Jesus Alberto Cardenas-De la Garza3, Rosa Arvizu-Rivera4, Valeria Gonzalez-Gonzalez5 and Angel Arias Peralta6, 1Rheumatology Service Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 2Hospital Universitario UANL, Monterrey, Mexico, 3Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico, 4Hospital Universitario "Dr. José Eleuterio Gonzalez", Escobedo, Mexico, 5Universidad Autónoma de Nuevo León, Monterrey, Mexico, 6Medicine Faculty, Universidad Autonoma De Nuevo Leon, Monterrey, Mexico

Meeting: ACR Convergence 2023

Keywords: Cardiovascular, Disease Activity, Imaging, rheumatoid arthritis, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0380–0422) RA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) leading cause of death is cardiovascular (CV) disease. RA patients can develop silent myocardial tissue alterations, which result in changes in left ventricular geometry (LVG) and increase CV morbidity and mortality. Echocardiography is a non-invasive tool that can detect subtle geometrical abnormalities. The purpose of this study is to compare the RA disease activity in patients with and without left ventricular geometry abnormalities

Methods: Descriptive, comparative, and cross-sectional study. We enrolled RA patients between 40 and 75 years old who fulfilled ACR/EULAR 2010 classification criteria. The disease activity was evaluated by DAS28-CRP. A transthoracic echocardiography was realized. Normal left ventricular geometry was defined as a left ventricular mass index ≤115 g/m² for men and ≤95 g/m² for women, and a relative wall thickness ≤0.42. Left ventricular abnormalities were considered as any value higher than normal. Normality was assessed by the Kolmogorov-Smirnov test. Variables were described by central tendency and dispersion measures. Differences between groups were analyzed by chi-squared test and Students’ t-test or Mann-Whitney U test, accordingly. Statistical significantly was p ≤ 0.05.

Results: A total of 158 RA patients were included. Demographic characteristics are presented in Table 1. Patients with LVG abnormalities were older (58.3 vs 54.4 years; p=0.009). There were no differences in sex and comorbidities (Table 1). The group with LVG abnormalities had higher disease activity (3.4 vs 2.7; p=0.022) and C reactive protein levels (0.8 vs 0.5; p=0.026). More patients with abnormalities in LVG used prednisone than those with normal LVG (73.1% vs 51.0%; p=0.008). There were no differences in disease duration or serology (Table 2).

Conclusion: RA patients with LVG abnormalities had higher disease activity and C reactive protein levels, and current prednisone use than those with normal LVG. Echocardiography may be a useful tool to detect early and subtle LVG abnormalities, particularly in patients with those characteristics.

Supporting image 1

This table shows a comparison of demographic characteristics and comorbidities between groups. LVG left ventricular geometry; SD standard deviation; T2DM type 2 diabetes mellitus; NS No significative.

Supporting image 2

This table shows a comparison of disease characteristics between groups. LVG left ventricular geometry; iQR interquartile range; CRP C reactive protein; ESR erythrocyte sedimentation rate; ACPA anticitrullinated peptide antibody; RF rheumatoid factor; NS no significative.


Disclosures: V. Beltran: None; I. Colunga: None; D. Galarza-Delgado: None; J. Azpiri-López: None; J. Cardenas-De la Garza: None; R. Arvizu-Rivera: None; V. Gonzalez-Gonzalez: None; A. Arias Peralta: None.

To cite this abstract in AMA style:

Beltran V, Colunga I, Galarza-Delgado D, Azpiri-López J, Cardenas-De la Garza J, Arvizu-Rivera R, Gonzalez-Gonzalez V, Arias Peralta A. Left Ventricular Geometry Abnormalities Are Related to Higher Clinical Activity in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/left-ventricular-geometry-abnormalities-are-related-to-higher-clinical-activity-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/left-ventricular-geometry-abnormalities-are-related-to-higher-clinical-activity-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology